Patents for C12R 1 - Micro-organisms (92,025) |
---|
05/14/1991 | US5015573 DNA vectors and their use in recombinant DNA technology |
05/14/1991 | US5015568 Quantitative analysis of antibodies and antigens for b-cells |
05/14/1991 | US5015385 Process for promotion of microbial consumption of waste water fats |
05/14/1991 | CA2068520A1 Type-b rotavirus cultures and uses thereof |
05/14/1991 | CA2045524A1 Diagnostic proteins to test for more than one antibody |
05/14/1991 | CA2044627A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | CA2044609A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
05/14/1991 | CA2029766A1 Polypeptide compound and a process for preparation thereof |
05/14/1991 | CA1284119C Expression method using recombinant bombyx mori nuclear polyhedrosis virus dna |
05/08/1991 | WO1991006305A1 Oligomeric immunoglobulins |
05/08/1991 | EP0426656A2 Process for the preparation of 2-arylpropionic acids |
05/08/1991 | EP0426557A1 Process for the preparation of 2-(3-pyridyl)-tetrahydrothiopyran-2-carbothiamide-1-(1R,2R)oxydes, the 2-(3-pyridyl)-tetrahydrothiopyran-2-carbothiamide-1-(1R,2R)oxydes and so obtained and pharmaceutical compositions containing them |
05/08/1991 | EP0426504A1 Detoxification of certain environmental protection agency declared toxicants by naturally occurring anaerobic organisms |
05/08/1991 | EP0426463A2 Method of encapsulating biologically active substances, a capsule produced by the method, its use, and a fodder containing such capsules |
05/08/1991 | EP0426458A2 Human monocyte growth factor |
05/08/1991 | EP0425995A2 Use of conserved oligonucleotide primers to amplify human papillomavirus DNA sequences |
05/08/1991 | EP0425661A1 A new method for tapping the immunological repertoire |
05/08/1991 | EP0425597A1 A tryptamine producing tryptophan decarboxylase gene of plant origin |
05/08/1991 | EP0425587A1 Process for determining biological activities in a sample and a device for implementing it. |
05/08/1991 | EP0425580A1 Synthetic hiv protease gene and method for its expression |
05/08/1991 | EP0425563A1 Process for amplifying and detecting nucleic acid sequences. |
05/08/1991 | EP0425549A1 Novel proteins, dna coding for said proteins, and their use |
05/08/1991 | EP0425536A1 Nonglycosylated human interleukin-3 compositions |
05/08/1991 | EP0425482A1 Human insulin analogs and preparations containing them. |
05/08/1991 | DE4009999A1 Preservation of silage |
05/08/1991 | CN1051200A Improved process for production of a-21978c derivatives |
05/08/1991 | CN1051199A Modified biological material |
05/08/1991 | CA2045150A1 Oligomeric immunoglobulins |
05/08/1991 | CA2029457A1 Modified forms of human erythropoietin and dna sequences encoding genes which can express them |
05/07/1991 | US5013757 Physiologically active substance Tan-931, its derivatives, their production and use |
05/07/1991 | US5013661 Lipopolysaccharide-specific acyloxyacyl hydrolase |
05/07/1991 | US5013657 Subtilisin mutations |
05/07/1991 | US5013656 Culturing Corynebacterium |
05/07/1991 | US5013655 Process for the preparation of colorants or monacolin K in a sterile fluidized bed of low water content |
05/07/1991 | US5013550 Antibiotics called "chloropolysporins B and C", a process for their preparation, and their therapeutic and veterinary use |
05/07/1991 | CA2027601A1 Antitumor antibiotic bu-3983t |
05/07/1991 | CA1283878C PROCESS FOR PRODUCING D-.alpha.-AMINO ACIDS |
05/07/1991 | CA1283876C High-yield methane production process by culture of methanobacterium thermoautotrophicum or any other methanogenic bacterium having the same physiological growth properties |
05/07/1991 | CA1283874C Process for inducing secondary metabolite production in plant cultures and means therefor |
05/07/1991 | CA1283872C Process for the degradation of environmentally persistent organic compounds |
05/04/1991 | WO1991006627A1 Nested-cone separator |
05/04/1991 | WO1991006317A1 Cross-protective salmonella vaccines |
05/04/1991 | CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
05/04/1991 | CA2072633A1 Cross-protective salmonella vaccines |
05/04/1991 | CA2072141A1 Nested-cone separator |
05/04/1991 | CA2029126A1 Use of conserved oligonucleotide primers to amplify human papillomavirus dna sequences |
05/02/1991 | WO1991006009A1 N-acetylmuramidase m1 |
05/02/1991 | WO1991005871A1 Bispecific heteroantibodies with dual effector functions |
05/02/1991 | WO1991005867A1 Erythropoietin isoforms |
05/02/1991 | WO1991005866A1 Novel expression systems utilizing bacteriophage t7 promoters and gene sequences |
05/02/1991 | WO1991005864A1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
05/02/1991 | WO1991005862A1 cDNA FRAGMENT CODING THE ALPHA INTERFERON RECEPTOR GENE AND PROCESS FOR THE PREPARATION OF A CORRESPONDING PROTEIN |
05/02/1991 | WO1991005858A1 A microperoxidase preparation containing a hemopeptide as an active component |
05/02/1991 | WO1991005855A1 Modified biological material |
05/02/1991 | WO1991005853A1 Growth hormone antagonists |
05/02/1991 | WO1991005802A1 Osteogenic devices |
05/02/1991 | WO1991005798A1 Compositions and methods for treating or preventing infections in canine and feline animals |
05/02/1991 | WO1991005795A1 Stem cell factor |
05/02/1991 | WO1991005475A1 Antifungal microorganism |
05/02/1991 | EP0425082A1 Bordetella vaccines |
05/02/1991 | EP0425001A1 Natural delta-lactones and process of the production thereof |
05/02/1991 | EP0424990A1 The manufacture and expression of large structural genes |
05/02/1991 | EP0424771A1 Plasmids and hosts for the expression of INA protein (ice nucleating protein) |
05/02/1991 | EP0424748A1 Synthetic envelope peptides of HTLV-I |
05/02/1991 | EP0424519A1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship. |
05/02/1991 | EP0424437A1 Recombinant mycobacterial expression vehicles and uses therefor |
05/02/1991 | EP0424429A1 New expression vectors |
05/02/1991 | EP0424413A1 Dna segment, plasmid containing this segment, transformed bacteria and transformed plant material |
05/02/1991 | EP0205564B1 Method for the production of erythropoietin |
05/02/1991 | EP0195802B1 Thermostable g(b)-amylase - |
05/02/1991 | CA2067235A1 Modified biological material |
05/02/1991 | CA2042577A1 Osteogenic devices |
05/01/1991 | WO1991006652A1 Outer membrane protein p1 and peptides of haemophilus influenzae type b |
05/01/1991 | WO1991006651A1 Gene conferring salt tolerance |
05/01/1991 | WO1991006641A1 Enhancement of cell growth by expression of a cloned hemoglobin gene |
05/01/1991 | CN1051058A Cloning and expression of microbial phytase |
05/01/1991 | CN1012499B Compounds related to antibiotic tan-749 and their production |
05/01/1991 | CA2072149A1 Enhancement of cell growth by expression of a cloned hemoglobin gene |
05/01/1991 | CA2070395A1 Gene conferring salt tolerance |
05/01/1991 | CA2028985A1 Process for the preparation of (pyridyl-3)-2 tetrahydrothiopyranecarbothioamide-2-oxydes-1-(1r,2r), (pyridyl-3)-2 tetrahydrothiopyranecarbothioamide-2-oxydes-1-(1r,2r) thus obtained and pharmaceutical compositions containing the |
05/01/1991 | CA2028763A1 24-and 25-substituted avermectin and milbemycin derivatives |
04/30/1991 | US5011952 Phospholipase A2 inhibitor |
04/30/1991 | CA1283614C D-amino acid oxidase and method for isolation thereof |
04/28/1991 | WO1991006650A1 C1 inhibitor muteins and uses thereof |
04/28/1991 | WO1991006572A1 Diagnosis of glomerulonephritis |
04/28/1991 | WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
04/28/1991 | CA2071871A1 C1 inhibitor muteins and uses thereof |
04/28/1991 | CA2071530A1 Diagnosis of glomerulonephritis |
04/28/1991 | CA2071502A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
04/28/1991 | CA2028517A1 Enhancement of porcine somatotropin activity |
04/26/1991 | WO1991006677A1 Receptor infection assay |
04/26/1991 | WO1991006673A1 ISOLATING OF STRAINS OF SACCHAROMYCES CEREVISIAE HAVING ALTERED Nα-ACETYLTRANSFERASE ACTIVITY |
04/26/1991 | WO1991006636A1 Identification of methionine n-alpha-acetyltransferase |
04/26/1991 | CA2071486A1 Isolating of strains of saccharomyces cerevisiae having altered n.alpha.-acetyltransferase activity |
04/26/1991 | CA2067757A1 Identification of methionine n-alpha-acetyltransferase |
04/26/1991 | CA2067216A1 Receptor infection assay |
04/26/1991 | CA2027852A1 Food additives |
04/25/1991 | WO1991006647A1 Gastrin releasing peptide receptor |
04/25/1991 | WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor |